$ Pollux Prop/ SG1I77884290 /
17/05/2024 10:02:03 | Chg. - | Volume | Bid04:00:29 | Ask11:01:02 | High | Low |
---|---|---|---|---|---|---|
0.028SGD | - | 944,300 Turnover: 24,943.600 |
0.025Bid Size: - | 0.028Ask Size: - | 0.028 | 0.026 |
GlobeNewswire
13:15
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
GlobeNewswire
13:10
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession Licen...
GlobeNewswire
13:07
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
GlobeNewswire
13:05
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
13:00
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
GlobeNewswire
13:00
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
13:00
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
13:00
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on AB...
GlobeNewswire
13:00
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC)...
GlobeNewswire
13:00
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
GlobeNewswire
13:00
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
GlobeNewswire
13:00
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therap...
GlobeNewswire
13:00
BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Grassy Mountain Gold and Silver Mi...